Ireland Bioinformatics Market Analysis Report [2022-30] I Insights10

Ireland Bioinformatics Market Analysis

$ 3999

The Ireland Bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of yy% during the forecast period of 2022 - 2030. The main factors driving the growth would be a strong biotech and pharmaceutical industry, a growing healthcare industry, and government support. The market is segmented by technology and by application. Some of the major players include Zifo (IRL), Nuritas (IRL), Genuity Science, Agilent Technologies, and IBM Life. Sciences.

ID: IN10IEHS001 CATEGORY: Healthcare Services GEOGRAPHY: Ireland AUTHOR: Neha Davda

Buy Now

Ireland Bioinformatics Market Executive Summary

The Ireland Bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of yy% during the forecast period of 2022 - 2030. In 2019, national healthcare spending in Ireland as a percentage of GDP reached 6.68% or $5,429 per capita. Ireland spends nearly as much on healthcare per person as the EU average.

The field of bioinformatics, which combines biology with information technology, connects biological data with methods for information storage, distribution, and analysis to serve a variety of scientific fields, including biomedicine. It makes use of software tools for data management, data warehousing, data mining, and other functions. Exploiting such data produces scientific findings that are applied to the study of genetics and genomes. The European region holds the second-largest market share for bioinformatics globally.

Market Dynamics

Market Growth Drivers

The Ireland bioinformatics market is expected to be driven by factors such as the strong biotech and pharmaceutical industry, the growing healthcare industry, and government support. Also, Ireland holds strong international partnerships and collaborations which may help to draw foreign capital into the bioinformatics business.

Market Restraints

The factors that are limiting the growth of the bioinformatics market in Ireland are the shortage of skilled professionals in this field, the high cost of research and development of bioinformatics software and tools, and limited funding for start-ups. Also, Ireland's market is relatively small compared to other European nations, which can reduce the market's potential for expansion.

Competitive Landscape

Key Players

Zifo (IRL)
Nuritas (IRL)
Genuity Science
Agilent Technologies
IBM Life Sciences

Notable Recent Deals

December 2022: Zifo collaborated with Gilead Digital, a well-known digital marketing company. Gilead Digital will assist the business in expanding further and enhancing its presence and reach among its targeted audience on the web using its integrated marketing tactics.

Healthcare Policies and Regulatory Landscape

Ireland features a dual healthcare system with access to both public and private healthcare. The Health Service Executive, a single government agency, oversees Ireland's public healthcare system (HSE). The Health Information and Quality Authority (HIQA) is in charge of making sure that healthcare practitioners adhere to predetermined standards of treatment, while the Department of Health is in charge of formulating overall healthcare policies and regulations in Ireland. Additionally, the Health Items Regulatory Authority (HPRA) is in charge of policing the efficacy, efficacy, and quality of healthcare products, such as medications, medical equipment, and other health products.

Reimbursement Scenario

The Health Service Executive (HSE), which oversees the country's public healthcare system, sets the policies for reimbursement of medical bills. Although the HSE covers a variety of treatments and procedures, there might be some restrictions or limitations on particular types of care. For instance, there can be restrictions on the number of times a particular doctor can be seen, or some prescriptions might not be covered.

The State-funded public healthcare system and private health insurance are used in conjunction to pay for healthcare services. The majority of medical costs, including doctor visits, hospital stays, and prescription medications, are covered by the public healthcare system. However, the amount of compensation may differ depending on the exact surgery or treatment, and some services might not even be covered. Additionally, those who have private health insurance may be able to obtain surgeries or treatments that are not covered by the public healthcare system, as well as a greater selection of reimbursement possibilities.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.